Showing results (61-70 of 6,996) with videos related to

Sort By:
Pageof 700
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
Predicting death from surgery for lung cancer: A comparison of two scoring systems in two European countriesEmma L O'Dowd, Margreet Lüchtenborg, David R Baldwin, et al.
Lung Cancer (Amsterdam, Netherlands)|April 5, 2016
EGFR, KRAS and ROS1 variants coexist in a lung adenocarcinoma patientLixia Ju, Mingquan Han, Chao Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective studyToby Talbot, Adam Dangoor, Riyaz Shah, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomasNadia Dandachi, Verena Tiran, Joerg Lindenmann, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP)Luis Corrales-Rodríguez, Oscar Arrieta, Luis Mas, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatmentYuko Kawano, Eiji Iwama, Kenji Tsuchihashi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 30, 2015
Lung cancer at the intensive care unit: The era of targeted therapyValerie Adam, Christophe Dooms, Johan Vansteenkiste
Lung Cancer (Amsterdam, Netherlands)|June 4, 2015
Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world settingMarion Sassier, Audrey Emmanuelle Dugué, Bénédicte Clarisse, et al.
Lung Cancer (Amsterdam, Netherlands)|February 12, 2025
Longitudinal recurrence risk of adjuvant cytotoxic chemotherapy and gefitnib in resected lung cancer: A combined analysis of phase III studiesHiroaki Akamatsu, Tomomi Nishikawa, Yuriko Takeda, et al.
Lung Cancer (Amsterdam, Netherlands)|February 9, 2025
Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smokingJoshua E Reuss, Jacob Zaemes, Nishant Gandhi, et al.
Pageof 700